Practical Dermatology

🖐 📈 THE IMPACT OF HAND ECZEMA: A recent study presented at Revolutionizing Atopic Dermatitis (RAD) Conference looked at the impact that even mild cases of hand eczema can have on patient quality of life. Dermatologist Lisa Swanson, MD, provides commentary on the analysis results. Full story ➡️ https://lnkd.in/e8Zw-eUN #skin #dermatology #atopicdermatitis #eczema #skinhealth

NEW DERMWIRE TV 📺 🎙️ In this week's DermwireTV, the FDA approves VTAMA® (tapinarof) cream, 1% HCP for atopic dermatitis in adults and children; the FDA approves Nemluvio (nemolizumab) for moderate-to-severe AD; and the president of Nuance Medical discusses the acquisition of scar treatment brand, Biocorneum. Watch here ➡️ https://lnkd.in/eThUc_tW #skin #dermatology #atopicdermatitis #skinhealth #nemolizumab #Vtama

🎙️ C-SUITE CHAT: Mark Steele, President of Nuance Medical, discusses the need for dermatologists to serve as comprehensive skin solution providers, and how the recent acquisition of Biocorneum will help meet consumer demands. Watch the video ➡️ https://lnkd.in/ey9rwrth #skin #dermatology #skincare #skinhealth #providers

📊 🔬 UPADACITINIB SAFE: Long-term safety matters, and a new six-year study of upadacitinib provides evidence of its stable safety outcomes over 9,000+ patient-years in two different dosing groups. Study co-author and dermatologist Lisa Swanson, MD, provides insights and what physicians can take from the study. These data were shared at the recent Revolutionizing Atopic Dermatitis Conference. Read more ➡️ https://lnkd.in/edB-bNC7 #AtopicDermatitis #JAKInhibitor #skin #dermatology #upadacitinib #Rinvoq

📣 📊 🔬 NEW STUDY RESULTS: Data from the ADapt study presented at the recent Revolutionizing Atopic Dermatitis (RAD) Conference indicated #lebrikizumab improved skin clearance, reduced itch, and enhanced quality of life in patients with moderate-to-severe atopic dermatitis for whom dupilumab was not effective. Study co-author and Practical Dermatology editorial board member Raj Chovatiya, MD, PhD, MSCI, provides key insights on the results. Read more ➡️ https://lnkd.in/e9j888RM #skin #atopicdermatitis #lebrikizumab #skinhealth

📣🩺 The December 2024 issue of Practical Dermatology takes a look back at the trends from this year and peeks into 2025 with what's ahead. Dive in! 📖 IN THE ISSUE: 💡2024 in Review – Top dermatology trends 💡 Scar-free Cyst Removal – Check out this minimally invasive technique 💡 JAK Inhibitors in Hidradenitis Suppurativa – An in-depth systematic review ALSO INSIDE: ✅ Reflections on mentorship and fulfillment from Dr. Peter Lio ✅ Case report: Adnexal clear cell #carcinoma with comedonecrosis ✅ Strategies for maximizing practice valuation: A Q&A with Dana Jacoby ✅ Treatment insights for #vitiligo Find the issue here ➡️ https://lnkd.in/eqBMu2fc #dermatology #skin #practicemanagement #atopicdermatitis #2024trends #skincaretrends #hidradenitissuppurativa

🚨 🗞️ BREAKING NEWS: Dermavant Sciences, an Organon company announced this morning that VTAMA (tapinarof) cream, 1%, has been approved by the FDA for topical treatment of atopic dermatitis in adults and pediatric patients 2 and older. We spoke with Phil Brown, MD, JD, Dermatologic Scientific Lead at Organon, about the importance of this development!

🔬💼 FUNDING UPDATE: Veradermics has announced the closing of a $75 million Series B financing, proceeds of which will be used to fund the ongoing clinical development of the company’s lead candidate VDPHL01 for the treatment of androgenetic alopecia (AGA), or pattern hair loss (PHL).💊 📖 Read more: https://bit.ly/41w7NMp #dermatologyInnovation #dermatology #hair #alopecia #Veradermics

📚 🔎 📣 MAKING PROGRESS: A new analysis of melasma clinical trials shows significant gender and racial representation progress, with potential implications for research inclusivity in other conditions. Read the story ➡️ https://lnkd.in/eixNwM2a #skin #dermatology #melasma #skinhealth

🌏 🏥 INCREASING GLOBAL ACCESS: In this Dermwire TV Extra, Esther Freeman, MD, PhD, Associate Professor of Dermatology at Harvard Medical School and Director of Global Health Dermatology at Massachusetts General Hospital, talks with Practical Dermatology about her work as principal investigator for the Global Access to Skin Health Observatory study. Dr. Freeman also serves as Vice Chair of the International Foundation of Dermatology with The International League of Dermatological Societies (ILDS), where she leads efforts to expand global access to skin health. Watch the video 📺 https://lnkd.in/ehkvauyb #dermatology #skin #skinhealth